Personal Information
Organization / Workplace
London United Kingdom
Occupation
Strategic Research Publisher
Industry
Consulting / Advisory
Website
www.vaczine-analytics.com
About
VacZine Analytics is a strategic research publisher based in the United Kingdom since 2007.
We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry.
Our key focus is helping clients build the case for developing new vaccines and immune-based therapies.
Tags
immuno-oncology
oncology
car-t
juno therapeutics
kite pharma
ctl019 (tisagenlecluecel-t)
kymriah
cell therapy
commercial analysis
commercial opportunity assessment
prescription pain killers
heroin
drug addiction
opioid crisis
new vaccines
opioids
venclexta
btk refractory
zydelig
ibrutinib
market forecast
novartis
chronic lymphocytic leukemia
leukemia
axi-cel/kte-c19
non-hodgkins lymphoma
allogeneic hematologic stem cell transplants
b-all
regenerative medicine
ctl019 (tisagenlecleucel-t)
cancer
acute lymphoblastic leukaemia
See more
Documents
(4)Likes
(3)Current challenges in pertussis prevention gaurav gupta - sept 2016
Gaurav Gupta
•
7 years ago
Update on Pertussis with special reference to QUINVAXEM in India
Gaurav Gupta
•
9 years ago
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
WAidid
•
9 years ago
Personal Information
Organization / Workplace
London United Kingdom
Occupation
Strategic Research Publisher
Industry
Consulting / Advisory
Website
www.vaczine-analytics.com
About
VacZine Analytics is a strategic research publisher based in the United Kingdom since 2007.
We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry.
Our key focus is helping clients build the case for developing new vaccines and immune-based therapies.
Tags
immuno-oncology
oncology
car-t
juno therapeutics
kite pharma
ctl019 (tisagenlecluecel-t)
kymriah
cell therapy
commercial analysis
commercial opportunity assessment
prescription pain killers
heroin
drug addiction
opioid crisis
new vaccines
opioids
venclexta
btk refractory
zydelig
ibrutinib
market forecast
novartis
chronic lymphocytic leukemia
leukemia
axi-cel/kte-c19
non-hodgkins lymphoma
allogeneic hematologic stem cell transplants
b-all
regenerative medicine
ctl019 (tisagenlecleucel-t)
cancer
acute lymphoblastic leukaemia
See more